The table below lists insider purchases and sales reported by company officers, directors, and major shareholders during the last 12 months.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Aug 08, 2025 Morgan Adam |
Morgan Adam
|
Buy |
70,012 | $15.00 | 70,012 $15.00 $105,018 |
Aug 08, 2025 Morgan Adam |
Morgan Adam
|
Buy |
1,766,546 | $1.50 | 1,766,546 $1.50 $0 |
Aug 08, 2025 Rubric Capital Management LP |
Rubric Capital Management LP
|
Buy |
2,387,225 | $1.50 | 2,387,225 $1.50 $3,580,838 |
Nov 17, 2023 Forbes William P |
Forbes William P
EVP, Chief Development Officer
|
Buy |
25,000 | $1.09 | 25,000 $1.09 $27,250 |
Nov 16, 2023 Duarte Ira |
Duarte Ira
EVP, Chief Financial Officer
|
Buy |
85,000 | $0.89 | 85,000 $0.89 $75,599 |
Nov 16, 2023 Collard Craig A |
Collard Craig A
CEO
|
Buy |
150,000 | $0.92 | 150,000 $0.92 $137,970 |
Nov 16, 2023 Forbes William P |
Forbes William P
EVP, Chief Development Officer
|
Buy |
50,000 | $0.94 | 50,000 $0.94 $46,995 |
Jul 21, 2023 Morgan Adam |
Morgan Adam
|
Buy |
1,162,891 | $1.37 | 1,162,891 $1.37 $0 |
Jul 21, 2023 Morgan Adam |
Morgan Adam
|
Buy |
2,486,744 | $1.37 | 2,486,744 $1.37 $0 |
May 03, 2022 MANHARD KIMBERLY |
MANHARD KIMBERLY
EVP, Drug Development
|
Sell |
1,504 | $4.76 | 1,504 $4.76 $7,154 |
Dec 21, 2021 Johnson Craig A |
Johnson Craig A
|
Sell |
250 | $9.73 | 250 $9.73 $2,432 |
Dec 21, 2021 Christian Waage |
Christian Waage
|
Sell |
300 | $9.73 | 300 $9.73 $2,920 |
Sep 21, 2021 Johnson Craig A |
Johnson Craig A
|
Sell |
250 | $12.30 | 250 $12.30 $3,074 |
Sep 21, 2021 Christian Waage |
Christian Waage
|
Sell |
300 | $12.31 | 300 $12.31 $3,692 |
May 03, 2021 MANHARD KIMBERLY |
MANHARD KIMBERLY
EVP, Drug Development
|
Sell |
1,529 | $17.66 | 1,529 $17.66 $27,009 |
Apr 15, 2021 Christian Waage |
Christian Waage
|
Sell |
300 | $17.51 | 300 $17.51 $5,254 |
Apr 06, 2021 Johnson Craig A |
Johnson Craig A
|
Sell |
250 | $17.22 | 250 $17.22 $4,305 |
Jan 14, 2021 Szekeres David Leslie |
Szekeres David Leslie
EVP, Chief Operating Officer
|
Sell |
827 | $18.09 | 827 $18.09 $14,960 |
Jan 08, 2021 Szekeres David Leslie |
Szekeres David Leslie
EVP, Chief Operating Officer
|
Sell |
3,571 | $19.66 | 3,571 $19.66 $70,219 |
Dec 22, 2020 MANHARD KIMBERLY |
MANHARD KIMBERLY
EVP, Drug Development
|
Sell |
10,000 | $20.00 | 10,000 $20.00 $200,000 |
May 01, 2020 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
1,158 | $13.97 | 1,158 $13.97 $16,176 |
Nov 29, 2019 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
24,000 | $26.00 | 24,000 $26.00 $624,000 |
Oct 04, 2019 TANG KEVIN C |
TANG KEVIN C
|
Buy |
285,714 | $17.50 | 285,714 $17.50 $4,999,995 |
Oct 03, 2019 Quart Barry D |
Quart Barry D
CEO
|
Buy |
4,571 | $17.50 | 4,571 $17.50 $79,993 |
Oct 03, 2019 POYHONEN JOHN |
POYHONEN JOHN
EVP, Chief Commercial Officer
|
Buy |
5,143 | $17.50 | 5,143 $17.50 $90,003 |
May 22, 2019 POYHONEN JOHN |
POYHONEN JOHN
|
Buy |
3,000 | $17.55 | 3,000 $17.55 $52,650 |
May 15, 2019 Christian Waage |
Christian Waage
|
Buy |
1,400 | $18.04 | 1,400 $18.04 $25,262 |
May 01, 2019 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
1,109 | $18.86 | 1,109 $18.86 $20,918 |
Nov 02, 2018 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
494 | $30.62 | 494 $30.62 $15,125 |
Oct 01, 2018 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
6,000 | $32.07 | 6,000 $32.07 $192,433 |
Sep 12, 2018 TANG KEVIN C |
TANG KEVIN C
|
Sell |
2,695,000 | $35.75 | 2,695,000 $35.75 $96,346,250 |
Jul 02, 2018 Rosen Robert |
Rosen Robert
President
|
Sell |
92,131 | $38.13 | 92,131 $38.13 $3,512,918 |
Jul 02, 2018 Rosen Robert |
Rosen Robert
President
|
Sell |
3,400 | $38.75 | 3,400 $38.75 $131,765 |
Jul 02, 2018 HOFFMAN ROBERT |
HOFFMAN ROBERT
CFO & SVP, Finance
|
Sell |
1,060 | $38.80 | 1,060 $38.80 $41,123 |
Jul 02, 2018 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
100 | $38.85 | 100 $38.85 $3,885 |
Jul 02, 2018 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
5,900 | $37.51 | 5,900 $37.51 $221,294 |
Jul 02, 2018 HOFFMAN ROBERT |
HOFFMAN ROBERT
CFO & SVP, Finance
|
Sell |
28,940 | $38.15 | 28,940 $38.15 $1,104,107 |
Jun 29, 2018 Rosen Robert |
Rosen Robert
President
|
Sell |
51,696 | $40.17 | 51,696 $40.17 $2,076,597 |
Jun 29, 2018 Rosen Robert |
Rosen Robert
President
|
Sell |
2,112 | $41.39 | 2,112 $41.39 $87,415 |
Jun 29, 2018 Rosen Robert |
Rosen Robert
President
|
Sell |
75,661 | $39.14 | 75,661 $39.14 $2,961,122 |
Jun 21, 2018 Quart Barry D |
Quart Barry D
CEO
|
Sell |
50,000 | $39.05 | 50,000 $39.05 $1,952,500 |
Mar 29, 2018 TANG KEVIN C |
TANG KEVIN C
|
Buy |
192,308 | $26.00 | 192,308 $26.00 $5,000,008 |
Mar 19, 2018 Quart Barry D |
Quart Barry D
CEO
|
Sell |
100,000 | $29.75 | 100,000 $29.75 $2,975,000 |
Mar 19, 2018 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
18,000 | $30.00 | 18,000 $30.00 $540,000 |
Mar 14, 2018 Quart Barry D |
Quart Barry D
CEO
|
Sell |
100,000 | $24.75 | 100,000 $24.75 $2,475,000 |
Jan 10, 2018 MANHARD KIMBERLY |
MANHARD KIMBERLY
Executive VP, Drug Development
|
Sell |
7,584 | $20.00 | 7,584 $20.00 $151,680 |
TOP
